Cargando…

Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease

Parkinson's disease (PD) is slowly progressive, and heterogeneity of its severity among individuals may be due to endogenous mechanisms that counterbalance the striatal dopamine loss. In this perspective paper, we introduce a neuroimaging-genetic approach to identify genetic variants, which may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenbaum, Lior, Lorberboym, Mordechai, Melamed, Eldad, Rigbi, Amihai, Barhum, Yael, Kohn, Yoav, Khlebtovsky, Alexander, Lerer, Bernard, Djaldetti, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625833/ https://www.ncbi.nlm.nih.gov/pubmed/23596382 http://dx.doi.org/10.3389/fnins.2013.00052

Ejemplares similares

Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open‐Label Pilot Study
por: Khlebtovsky, Alexander, et al.
Publicado: (2019)

A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2
por: Lev, Nirit, et al.
Publicado: (2015)

Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes
por: Greenbaum, Lior, et al.
Publicado: (2015)

Association of the Type 2 Diabetes Mellitus Susceptibility Gene, TCF7L2, with Schizophrenia in an Arab-Israeli Family Sample
por: Alkelai, Anna, et al.
Publicado: (2012)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2011)

DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury
por: Molcho, Lior, et al.
Publicado: (2018)

Auditory Hallucinations in Acute Stroke
por: Lampl, Yair, et al.
Publicado: (2005)

Dopaminergic-Like Neurons Derived from Oral Mucosa Stem Cells by Developmental Cues Improve Symptoms in the Hemi-Parkinsonian Rat Model
por: Ganz, Javier, et al.
Publicado: (2014)

Compensatory weight gain due to dopaminergic hypofunction: new evidence and own incidental observations
por: Reinholz, Julia, et al.
Publicado: (2008)

Evaluation of Diagnostic Yield in Fetal Whole-Exome Sequencing: A Report on 45 Consecutive Families
por: Greenbaum, Lior, et al.
Publicado: (2019)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Compensatory neural mechanisms in cognitively unimpaired Parkinson disease
por: Poston, Kathleen L., et al.
Publicado: (2016)

Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson’s disease
por: Reiner, Johnathan, et al.
Publicado: (2023)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Decoding emotion of the other differs among schizophrenia patients and schizoaffective patients: A pilot study
por: Tadmor, Hagar, et al.
Publicado: (2016)

Compensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease
por: Simioni, Alison C., et al.
Publicado: (2015)

SEEG-RF for revealing and treating Geschwind syndrome's epileptic network: A case study
por: Levy, Mikael, et al.
Publicado: (2023)

Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease
por: Pérez-Santamarina, Estela, et al.
Publicado: (2021)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
por: Costa, Alberto, et al.
Publicado: (2008)

Dopaminergic modulation of the praxis network in Parkinson's disease
por: Matt, Eva, et al.
Publicado: (2019)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Parkinson’s disease, dopaminergic drugs and the plant world
por: Kempster, Peter, et al.
Publicado: (2022)

Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
por: Kim, Ji Hwan, et al.
Publicado: (2023)

Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
por: Gordon, Richard, et al.
Publicado: (2016)

Association of rare variants in ARSA with Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2023)

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
por: Tsika, Elpida, et al.
Publicado: (2014)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
Publicado: (2014)

Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014)

Dopaminergic modulation of motor network dynamics in Parkinson’s disease
por: Michely, Jochen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v8iibhpp2fbhvqkt9k0bfj61uq